Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
出版年份 2014 全文链接
标题
Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 8, Pages e104160
出版商
Public Library of Science (PLoS)
发表日期
2014-08-02
DOI
10.1371/journal.pone.0104160
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Central Neural Regulation of Brown Adipose Tissue Thermogenesis and Energy Expenditure
- (2014) Shaun F. Morrison et al. Cell Metabolism
- Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats
- (2014) Qingsheng Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
- (2014) Yueshan Hu et al. PLoS One
- Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats
- (2014) Qingsheng Zhang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats
- (2014) Meng He et al. PSYCHONEUROENDOCRINOLOGY
- The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain
- (2013) Meng He et al. CNS DRUGS
- Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance
- (2013) Chao Deng ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects
- (2013) Silje Skrede et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Evidence for the role of AMPK in regulating PGC-1 alpha expression and mitochondrial proteins in mouse epididymal adipose tissue
- (2013) Zhongxiao Wan et al. Obesity
- Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
- (2012) Jee-Eun Oh et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain
- (2012) Renan P. Souza et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model
- (2012) Chao Deng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Loss of histaminergic modulation of thermoregulation and energy homeostasis in obese mice
- (2012) J. Sethi et al. NEUROSCIENCE
- Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
- (2012) Katrina Weston-Green et al. PLoS One
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Immortalized neurons for the study of hypothalamic function
- (2011) Prasad S. Dalvi et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Three years with adult human brown adipose tissue
- (2011) Jan Nedergaard et al. Annals of the New York Academy of Sciences
- A Role for Hypothalamic AMP-Activated Protein Kinase in the Mediation of Hyperphagia and Weight Gain Induced by Chronic Treatment with Olanzapine in Female Rats
- (2011) Ei Sejima et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies
- (2011) Alessandro Zuddas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels
- (2011) Katrina Weston-Green et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Modeling chronic olanzapine exposure using osmotic minipumps: Pharmacological limitations
- (2011) Gary Remington et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
- (2011) Johan Fernø et al. PLoS One
- Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication
- (2011) Jelle Vehof et al. PSYCHOPHARMACOLOGY
- Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats
- (2010) Katrina Weston-Green et al. BEHAVIOURAL BRAIN RESEARCH
- Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
- (2010) P. J. F. Martins et al. DIABETES
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics
- (2010) Olawale Osuntokun et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
- (2010) Miguel López et al. NATURE MEDICINE
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
- (2010) Roberto Coccurello et al. PHARMACOLOGY & THERAPEUTICS
- Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole
- (2010) Jiamei Lian et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
- (2009) S. M. Stahl et al. ACTA PSYCHIATRICA SCANDINAVICA
- Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat
- (2009) Nima Davoodi et al. BEHAVIOURAL PHARMACOLOGY
- Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment
- (2009) Rocio Perez-Iglesias et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?
- (2009) Chao Deng et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
- (2009) Jayendra K. Patel et al. SCHIZOPHRENIA RESEARCH
- Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments
- (2008) Darrick T. Balu et al. BRAIN RESEARCH
- Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
- (2008) Stefan Gebhardt et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Building a better antipsychotic: Receptor targets for the treatment of multiple symptom dimensions of schizophrenia
- (2008) Dennis H. Kim et al. Neurotherapeutics
- The Role of Thermogenesis in Antipsychotic Drug-induced Weight Gain
- (2008) Aneta Stefanidis et al. Obesity
- Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression
- (2008) Mei Han et al. PSYCHONEUROENDOCRINOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started